AHA: Apixaban Beneficial for Patients With Subclinical A-Fib : vimarsana.com

Risk for stroke or systemic embolism lower with apixaban versus aspirin for patients with subclinical a-fib

Related Keywords

United States , Stockholm , Sweden , Canada , Philadelphia , Pennsylvania , American , Emma Svennberg , Jeffs Healey , Karolinska University Hospital , American Heart Association Scientific Sessions , Medtronic , Bristol Myers Squibb , Mcmaster University , Pfizer Alliance , Healthday News , New England Journal , Bristol Myers Squibb Pfizer Alliance ,